Announcements
Projects
Orgs
Project Post
Articles 130
Votes 0
Endpoints News

Authors 22

Max Gelman
Tyler Patchen
Lei Lei Wu
Amber Tong
John Carroll
Zachary Brennan
Kyle LaHucik
Nicole DeFeudis
Paul Schloesser
Katherine Lewin
Beth Snyder Bulik
Katherine
Andrew Dunn
Drew Armstrong
Ryan Cross
Jared Whitlock
Reynald Castañeda
Jaimy Lee
Ayisha Sharma
Anna Brown
Lia DeGroot
ENDPOINTS
Ginkgo and Boehringer Ingelheim sign pact to mine microbes and find new molecules - Endpoints News
~2y
Aerami Therapeutics CEO Lisa Yañez passes away, chair to lead heart disease biotech - Endpoints News
~2y
Acelyrin goes public in $540M IPO amid quiet biotech market – Endpoints News - Endpoints News
~2y
Novo Nordisk to restrict starter dose supply for weight loss drug Wegovy - Endpoints News
~2y
UPDATED: J&J goes blockbuster hunting (again) with $245M cash upfront for next-gen CAR-T - Endpoints News
~2y
Sanofi's next chapter in Pompe: $150M for Maze pact as the biotech gears up in CKD - Endpoints News
~2y
FDA approves Otsuka and Lundbeck's schizophrenia, bipolar disorder injection – Endpoints News - Endpoints News
~2y
AstraZeneca, Ionis post Phase III win for eplontersen, with $3B-plus on the line - Endpoints News
~2y
FDA adcomm votes in favor of first drug for agitation associated with Alzheimer's dementia - Endpoints News
~2y
Biotech and cancer center researchers star in Stand Up to Cancer's latest commercial - Endpoints News
~2y
Digital therapeutics maker Pear files for bankruptcy, lays off 170 staffers — including CEO - Endpoints News
>2y
Pfizer RSV data set up $10B showdown with GSK and Moderna for the next big vaccine market - Endpoints News
>2y
FDA spells out how cancer drug developers can use one trial for both accelerated and full approvals - Endpoints News
>2y
ViiV's newest campaign aims to normalize sex and health discussions to help HIV prevention among Black women - Endpoints News
>2y
Bristol Myers blasts off with SpaceX to study biomanufacturing in space - Endpoints News
>2y
Pfizer CEO points to IRA as a factor that made Seagen an attractive target - Endpoints News
>2y
FDA adcomm votes 11-2 to expand Roche's Polivy label in DLBCL - Endpoints News
>2y
Merck unwraps full PhIII data on the centerpiece from its $11.5B Acceleron buyout: #ACC23 - Endpoints News
>2y
July decision date set for full approval of Eisai's Alzheimer's drug, with an adcomm coming too - Endpoints News
>2y
Months after reorg, Adaptimmune merges with fellow cell therapy developer - Endpoints News
>2y
US spent nearly $32B in public funds on mRNA vaccine development, study finds - Endpoints News
>2y
BioNTech touts differences with Moderna in race for cancer vaccines - Endpoints News
>2y
Sorrento files for Chapter 11 after losing arbitration to Patrick Soon-Shiong biotech - Endpoints News
>2y
Bristol Myers, 2seventy roll out full Abecma data in earlier-stage cancer - Endpoints News
>2y
'Smooth and very much on track': Eisai reports first shipments of Leqembi - Endpoints News
>2y